Seven U.S. lawmakers asked the FDA to create a time frame for reclassifying hydrocodone drugs from Schedule III to Schedule II. The change would mean patients would need a physician's written prescription to be able to purchase the medications.
Lawmakers ask FDA for timeline on reclassifying hydrocodone
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||